Search research articles
Contact Us
Filters
Showing results (391-400 of 721) with videos related to
Page
of 73
Sort By:
Oncotarget
|
December 13, 2017
Targeting CXCR4 with [<sup>68</sup>Ga]Pentixafor: a suitable theranostic approach in pleural mesothelioma?
Constantin Lapa, Stefan Kircher, Andreas Schirbel, et al.
Plos One
|
July 18, 2015
Multiparametric MR and PET Imaging of Intratumoral Biological Heterogeneity in Patients with Metastatic Lung Cancer Using Voxel-by-Voxel Analysis
Stephan Metz, Carl Ganter, Sylvie Lorenzen, et al.
Frontiers in Psychology
|
September 9, 2020
COVID-19-Related Fear and Health-Related Safety Behavior in Oncological Patients
Venja Musche, Alexander Bäuerle, Jasmin Steinbach, et al.
International Journal of Molecular Sciences
|
July 24, 2021
Enzalutamide Enhances PSMA Expression of PSMA-Low Prostate Cancer
Magdalena Staniszewska, Pedro Fragoso Costa, Matthias Eiber, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 24, 2020
PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [<sup>177</sup>Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis
Robert Seifert, Katharina Kessel, Katrin Schlack, et al.
BMC Cancer
|
May 8, 2021
Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: study protocol
Jeremie Calais, Shaojun Zhu, Nader Hirmas, et al.
Cancers
|
April 30, 2021
Predictive Factors for RAI-Refractory Disease and Short Overall Survival in PDTC
David Kersting, Robert Seifert, Lukas Kessler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 2, 2023
Efficacy and Safety of <sup>124</sup>I-MIBG Dosimetry-Guided High-Activity <sup>131</sup>I-MIBG Therapy of Advanced Pheochromocytoma or Neuroblastoma
Ines Maric, Manuel Weber, Andre Prochnow, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 12, 2024
EANM expert opinion: How can lessons from radiobiology be applied to the design of clinical trials? Part I: back to the basics of absorbed dose-response and threshold absorbed doses
Jean-Pierre Pouget, Pablo Minguez Gabina, Ken Herrmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 4, 2018
Prospective comparison of <sup>18</sup>F-FDG PET/MRI and <sup>18</sup>F-FDG PET/CT for thoracic staging of non-small cell lung cancer
Julian Kirchner, Lino M Sawicki, Felix Nensa, et al.
Page
of 73
Search research articles
Search
Showing results (391-400 of 721) with videos related to
Sort By:
Page
of 73
Oncotarget
|
December 13, 2017
Targeting CXCR4 with [<sup>68</sup>Ga]Pentixafor: a suitable theranostic approach in pleural mesothelioma?
Constantin Lapa, Stefan Kircher, Andreas Schirbel, et al.
Plos One
|
July 18, 2015
Multiparametric MR and PET Imaging of Intratumoral Biological Heterogeneity in Patients with Metastatic Lung Cancer Using Voxel-by-Voxel Analysis
Stephan Metz, Carl Ganter, Sylvie Lorenzen, et al.
Frontiers in Psychology
|
September 9, 2020
COVID-19-Related Fear and Health-Related Safety Behavior in Oncological Patients
Venja Musche, Alexander Bäuerle, Jasmin Steinbach, et al.
International Journal of Molecular Sciences
|
July 24, 2021
Enzalutamide Enhances PSMA Expression of PSMA-Low Prostate Cancer
Magdalena Staniszewska, Pedro Fragoso Costa, Matthias Eiber, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 24, 2020
PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [<sup>177</sup>Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis
Robert Seifert, Katharina Kessel, Katrin Schlack, et al.
BMC Cancer
|
May 8, 2021
Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: study protocol
Jeremie Calais, Shaojun Zhu, Nader Hirmas, et al.
Cancers
|
April 30, 2021
Predictive Factors for RAI-Refractory Disease and Short Overall Survival in PDTC
David Kersting, Robert Seifert, Lukas Kessler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 2, 2023
Efficacy and Safety of <sup>124</sup>I-MIBG Dosimetry-Guided High-Activity <sup>131</sup>I-MIBG Therapy of Advanced Pheochromocytoma or Neuroblastoma
Ines Maric, Manuel Weber, Andre Prochnow, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 12, 2024
EANM expert opinion: How can lessons from radiobiology be applied to the design of clinical trials? Part I: back to the basics of absorbed dose-response and threshold absorbed doses
Jean-Pierre Pouget, Pablo Minguez Gabina, Ken Herrmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 4, 2018
Prospective comparison of <sup>18</sup>F-FDG PET/MRI and <sup>18</sup>F-FDG PET/CT for thoracic staging of non-small cell lung cancer
Julian Kirchner, Lino M Sawicki, Felix Nensa, et al.
Page
of 73